ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 203 out of 670

$587K Total Retail Price of All Prescriptions

Rank: 142 out of 670

574 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,608 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 386 338 1 2
AMLODIPINE BESYLATE 281 246 2 7
SIMVASTATIN 251 177 3 4
LISINOPRIL 245 207 4 3
OMEPRAZOLE 231 196 5 5
ATENOLOL 191 161 6 17
METOPROLOL SUCCINATE 179 165 7 12
ATORVASTATIN CALCIUM 174 150 8 15
HYDROCODONE-ACETAMINOPHEN 166 127 S3 9 1
SERTRALINE HCL 164 118 10 22
METFORMIN HCL 144 112 11 8
METOPROLOL TARTRATE 128 115 12 9
NEXIUM 124 97 13 14
FUROSEMIDE 121 108 14 6
PRAVASTATIN SODIUM 121 94 14 19
ZETIA 113 84 16 66
WARFARIN SODIUM 112 107 17 13
GLIMEPIRIDE 107 58 18 32
LOSARTAN POTASSIUM 98 76 19 26
CLOPIDOGREL 93 80 20 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 53 21 27
SYNTHROID 81 78 21 47
GLYBURIDE-METFORMIN HCL 80 56 R 23 157
HYDROCHLOROTHIAZIDE 79 72 24 10
FELODIPINE ER 79 68 24 144
TAMSULOSIN HCL 77 61 26 30
KLOR-CON M20 77 65 26 57
ALENDRONATE SODIUM 76 68 28 43
PLAVIX 69 68 29 34
ZOLPIDEM TARTRATE 69 66 29 23
DIOVAN 68 59 31 48
DONEPEZIL HCL 66 66 32 31
GABAPENTIN 66 48 32 11
RANITIDINE HCL 64 38 34 25
PANTOPRAZOLE SODIUM 61 47 35 41
LOVASTATIN 61 55 35 44
CRESTOR 60 46 37 18
TRAMADOL HCL 53 37 38 21
LOSARTAN-HYDROCHLOROTHIAZIDE 52 47 39 73
NAMENDA 51 51 40 54
VYTORIN 51 43 40 134
ALPRAZOLAM 51 45 40 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.